Mateya Trinkaus

1.5k total citations
13 papers, 252 citations indexed

About

Mateya Trinkaus is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mateya Trinkaus has authored 13 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mateya Trinkaus's work include Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mateya Trinkaus is often cited by papers focused on Bone health and treatments (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mateya Trinkaus collaborates with scholars based in Canada, Australia and New Zealand. Mateya Trinkaus's co-authors include Christine Simmons, Mark Clemons, Sheray N. Chin, Wendy Wolfman, George Dranitsaris, Danny Rischin, Rodney J. Hicks, David Binns, Mathias Bressel and Mark Clemons and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Oncologist.

In The Last Decade

Mateya Trinkaus

13 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mateya Trinkaus Canada 7 109 70 68 60 53 13 252
Akiou Okumura Japan 10 37 0.3× 29 0.4× 41 0.6× 12 0.2× 50 0.9× 38 312
Archana Rao Australia 9 63 0.6× 14 0.2× 58 0.9× 17 0.3× 27 0.5× 25 269
Ole‐Erik Iversen Norway 11 68 0.6× 68 1.0× 61 0.9× 11 0.2× 53 1.0× 26 346
Demetrios Minaretzis Greece 10 80 0.7× 79 1.1× 32 0.5× 11 0.2× 27 0.5× 15 489
Giulia Dondi Italy 11 45 0.4× 46 0.7× 17 0.3× 40 0.7× 11 0.2× 31 402
Marco A. Ramírez‐Ortiz Mexico 10 54 0.5× 13 0.2× 18 0.3× 68 1.1× 8 0.2× 28 306
Jacques Irani France 8 39 0.4× 67 1.0× 49 0.7× 18 0.3× 25 0.5× 12 338
Georgios Adonakis Greece 11 67 0.6× 13 0.2× 18 0.3× 17 0.3× 32 0.6× 46 359
Jason Tan Australia 11 34 0.3× 11 0.2× 28 0.4× 12 0.2× 46 0.9× 22 287
Westin R. Tom United States 7 71 0.7× 90 1.3× 18 0.3× 47 0.8× 26 0.5× 9 395

Countries citing papers authored by Mateya Trinkaus

Since Specialization
Citations

This map shows the geographic impact of Mateya Trinkaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mateya Trinkaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mateya Trinkaus more than expected).

Fields of papers citing papers by Mateya Trinkaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mateya Trinkaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mateya Trinkaus. The network helps show where Mateya Trinkaus may publish in the future.

Co-authorship network of co-authors of Mateya Trinkaus

This figure shows the co-authorship network connecting the top 25 collaborators of Mateya Trinkaus. A scholar is included among the top collaborators of Mateya Trinkaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mateya Trinkaus. Mateya Trinkaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bédard, Philippe L., Amit M. Oza, Blaise Clarke, et al.. (2016). Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials. Clinical Cancer Research. 22(1_Supplement). PR03–PR03. 5 indexed citations
2.
Trinkaus, Mateya, Rodney J. Hicks, Richard J. Young, et al.. (2014). Correlation of p16 status, hypoxic imaging using [18F]‐misonidazole positron emission tomography and outcome in patients with loco‐regionally advanced head and neck cancer. Journal of Medical Imaging and Radiation Oncology. 58(1). 89–97. 28 indexed citations
3.
Trinkaus, Mateya, Rob Blum, Danny Rischin, et al.. (2013). Imaging of hypoxia with 18FFAZA PET in patients with locally advanced non‐small cell lung cancer treated with definitive chemoradiotherapy. Journal of Medical Imaging and Radiation Oncology. 57(4). 475–481. 56 indexed citations
4.
Trinkaus, Mateya, A Coleman, Ieta D’Costa, Elizabeth Sigston, & Danny Rischin. (2012). Recurrent intestinal type sinonasal adenocarcinoma treated with FOLFOX6 chemotherapy: Case report and review of literature. International Journal of Case Reports and Images. 8(3). 17–17. 1 indexed citations
5.
Trinkaus, Mateya, Rodney J. Hicks, Richard J. Young, et al.. (2011). Correlation of HPV status and hypoxic imaging using [18F]-misonidazole (FMISO) PET in head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 29(15_suppl). 5527–5527. 1 indexed citations
6.
Trinkaus, Mateya, Debika Burman, Gary Rodin, et al.. (2010). Spirituality and use of complementary therapies for cure in advanced cancer. Psycho-Oncology. 20(7). 746–754. 16 indexed citations
7.
Trinkaus, Mateya, et al.. (2009). Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting. Supportive Care in Cancer. 18(2). 197–203. 30 indexed citations
8.
Chin, Sheray N., et al.. (2009). Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer. Clinical Breast Cancer. 9(2). 108–117. 56 indexed citations
9.
Simmons, Christine, et al.. (2008). Pharmacotherapy of bone metastases in breast cancer patients. Expert Opinion on Pharmacotherapy. 9(6). 937–945. 7 indexed citations
10.
Trinkaus, Mateya, et al.. (2008). Skeletal related events (SREs) in patients with bone metastases from breast cancer treated with intravenous (i.v.) bisphosphonates (BPs) in the non-trial setting. Journal of Clinical Oncology. 26(15_suppl). 1120–1120. 2 indexed citations
11.
Chin, Sheray N., et al.. (2008). The prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Journal of Clinical Oncology. 26(15_suppl). 20551–20551. 1 indexed citations
12.
Trinkaus, Mateya, Sheray N. Chin, Wendy Wolfman, Christine Simmons, & Mark Clemons. (2008). Should Urogenital Atrophy in Breast Cancer Survivors Be Treated with Topical Estrogens?. The Oncologist. 13(3). 222–231. 48 indexed citations
13.
Trinkaus, Mateya, Christine Simmons, Jeffrey N. Myers, George Dranitsaris, & Mark Clemons. (2008). P64. Skeletal related events (SREs) in patients with bone metastases from breast cancer treated with intravenous (i.v.) bisphosphonates (BPs) in the non-trial setting. Cancer Treatment Reviews. 34. 31–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026